S. M. Steinberg

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.

W. Wilson, S. Steinberg, S. Broder, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.

F. Ognibene, S. Steinberg, E. Kohn, 1994, Journal of the National Cancer Institute.

A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.

S. Steinberg, W. M. Linehan, P. Duray, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer.

S. Steinberg, M. Turner, M. Rudek, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833.

P. Choyke, T. Fojo, S. Bates, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain

P. Meltzer, S. Steinberg, K. Camphausen, 2011, Clinical & Experimental Metastasis.

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.

W. Wilson, S. Steinberg, R. Wittes, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of correlation between prostate-specific antigen and the presence of measurable soft tissue metastases in hormone-refractory prostate cancer.

S. Steinberg, N. Patronas, O. Sartor, 1996, Cancer investigation.

A pilot study of the PD-1 targeting agent AMP-224 combined with low-dose cyclophosphamide and stereotactic body radiation therapy in patients with metastatic colorectal cancer

M. Walker, A. Duffy, V. Krishnasamy, 2019 .

Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy.

S. Steinberg, P. Pizzo, L. Wexler, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.